SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazons sharp rally is drawing attention after Morgan Stanley named it a top pick, citing AWS growth and AI opportunities. Traders are broadly bullish, though some question whether the move can hold and point to earnings and technical resistance as potential tests.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

Goldman Sachs upgraded CoreWeave to Buy while lowering its price target, drawing attention after a sharp selloff in AI infrastructure stocks. Traders debated whether the upgrade and AI demand could support a rebound or whether heavy debt and financing concerns would keep pressure on the shares.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBios expanded FDA approval of ANKTIVA for papillary-only BCG-unresponsive bladder cancer, alongside long-term Phase 3 data showing durable responses and cystectomy avoidance, is driving attention. Traders are frustrated by the share-price drop despite the positive developments, debating a sell-the-news reaction and broader biotech weakness versus unverified claims of short-selling pressure.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Better-than-expected third-quarter results and a substantially more upbeat 2027 earnings outlook are driving CLF attention and a sharp rally. Traders are debating whether the forecast and steel-price tailwinds can overcome debt and execution concerns, while some view the move as vulnerable to profit-taking or short-covering volatility.

Sea Ltd. is an internet and mobile platform company, which engages in the provision of online gaming services. It operates through the following segments: Digital Entertainment, E-Commerce, and Digital Financial Services. The Digital Entertainment segment offers and develops mobile and PC online games. The E-Commerce segment manages a third-party marketplace through the Shopee mobile app and websites that connect buyers and sellers. The Digital Financial Services segment includes a variety of payment services and loans to individuals and businesses through SeaMoney. Sea was founded by Xiao Dong Li, Gang Ye, and Jing Ye Chen on May 8, 2009 and is headquartered in Singapore.

Sea Ltd - ADR

Sea shares are drawing attention after a sharp slide and technical breakdown, with traders repeatedly pointing to insider share sales as added selling pressure. Some view the sales as planned and the decline as disconnected from the companys growth, while others worry about management confidence and cite broader Southeast Asian market and oil-related risks.

Disc Medicine, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for hematologic diseases. It assembles a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. The company was founded in October 2017 and is headquartered in Watertown, MA.

Disc Medicine Inc

Disc Medicine is surging after bitopertin met all primary and secondary endpoints in the Phase 3 APOLLO trial for erythropoietic protoporphyria, strengthening the companys path toward an FDA resubmission. Traders are broadly bullish and debating a possible short squeeze, while some cite dizziness concerns and potential profit-taking.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

CBRS is drawing attention amid a steep post-IPO selloff, with traders pointing to successive insider-share unlocks and a broader AI and semiconductor pullback. Bears cite the companys high valuation, scaling concerns and OpenAI dependence, while bulls argue the decline is overdone and are buying dips.

Almonty Industries, Inc. engages in the mining, processing, and shipment of tungsten concentrates. Its projects include Almonty Korea Tungsten, Panasquiera mine, Gentung, Almonty Korea Moly, Los Santos mine, and Valtreixal. The company was founded on September 28, 2009 and is headquartered in Dillon, MT.

Almonty Industries Inc

Almontys investor-day webcast is driving concern, with traders criticizing CEO Lewis Blacks presentation and questioning whether it signaled an undisclosed problem. Others say the content sounded positive and see no clear negative update, leaving the selloffs cause uncertain.

X-Energy, Inc. engages in the development of advanced small modular nuclear reactors and fuel technology for clean energy generation. Its solutions include Xe-100 and TRISO-X. The company was founded by Kam Ghaffarian and Eben Mulder in 2009 and is headquartered in Rockville, MD.

X-Energy Inc. - Ordinary Shares- Class A

X-Energy Inc

Traders are focused on AEP and X-energy evaluating a potential 960-MW small modular reactor project in Indiana, with Amazon funding development and potentially buying power long termfueling optimism about nuclear power for data centers. The project remains at the evaluation stage, and enthusiasm over the opportunity is tempered by concern about XEs sharp selloff and the long path to commercial deployment.

Dynex Capital, Inc. is an internally managed mortgage real estate investment trust. It engages in the business of investing in mortgage-backed securities. The company was founded on December 18, 1987 and is headquartered in Glen Allen, VA.

Dynex Capital, Inc.

Dynexs Q3 results have focused attention on a sharp book-value decline as wider agency mortgage spreads drove losses, alongside earnings below the dividend payout. Traders are split between buying the dip on managements confidence in liquidity and future spread recovery, and worrying about dividend coverage and further share-price downside.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ORCL Stock Could Be Near A Turning Point, Says Jefferies As ‘Peak-Negative’ Investor Sentiment Sets In 

Equity

Oracle stock was heading for a fourth consecutive decline Wednesday after losing more than 7% over the previous three sessions.

SK Hynix Misses Estimates Despite Profit Surge: ETFs in Focus 

SK Hynix missed Q2 estimates despite record AI-driven growth, raising valuation concerns. See the ETFs that can play meaningful roles now. 

IREN Stock Rallied 12% Today, After More Than 200% Rise In Past Six Months – Retail Expects News

H.C. Wainwright double upgraded Iren to ‘Buy’ from ‘Sell’ with a price target of $80, up from $56.


NYSE Content Advisory: Pre-Market Update + Dan Ives to Ring NYSE Bell For His Wedbush AI Revolution ETF

NYSE Content Advisory: Pre-Market Update + Dan Ives to Ring NYSE Bell For His Wedbush AI Revolution ETF NYSE Content Advisory: Pre-Market Update + Dan Ives to Ring NYSE Bell For His Wedbush AI...

Alibaba Executive Reportedly Says Firm Beginning To See Return On AI Investment In E-Commerce: Expects ‘Very Significant’ Positive Impact

According to a CNBC report, Vice President Kaifu Zhang said initial testing has shown that AI has generated steady results with a 12% rise in advertising spend returns.

Meta, Microsoft Spark $500B Rally in AI Leaders and ETFs

META's and Microsoft's blowout earnings triggered a $500B surge in AI stocks and ETFs like WTAI, IVES and others.


ETF Strategies to Follow in 2H 2025

Markets hit new record with bets on a "Goldilocks" economy, but volatility persists. AI and international ETFs like QQQ, IVES and EZU could be good bets for 2H. 

Investing in the AI Revolution with Dan Ives

Wedbush Series Trust - Dan IVES Wedbush AI Revolution ETF

Neutral Sentiment

<ul class="summary-bullets"><li>Jefferies cut its Oracle price target to $290 from $320 but maintained a ‘Buy’ rating.</li><li>The firm believes stronger cloud growth and an uptick in SaaS could “dispel some of the bear thesis.”</li><li>TD Cowen also lowered its Oracle price target to $240 from $300 while maintaining a ‘Buy’ rating and pointing to the Oct. 28 analyst day as a key catalyst.</li></ul>Oracle (ORCL) shares were on track to fall for a fourth consecutive session Wednesday, but Jefferies said sentiment toward the stock is "near peak-negative" and much of the bad news may already be priced in.In a note to investors cited by TheFly, Jefferies analyst Brent Thill lowered the firm's price target on Oracle to $290 from $320 while maintaining a ‘Buy’ rating.<a href="https://stocktwits.com/symbol/ORCL">ORCL stock</a> fell as much as 1.5% in pre-market trade amid broader market weakness after a tumble of over 5% in the previous session. The stock has fallen over 7% in the last three days, on track to log a fourth day in the red.<figure class="image"><img src="https://news.stocktwits-cdn.com/koyfin_20260902_055555567_af0fbcf914.png" alt="koyfin_20260902_055555567.png" width="2400" height="1240"><figcaption>ORCL stock’s single-day gains over the past month. | Source: Koyfin</figcaption></figure>On Stocktwits, retail sentiment around the company trended in ‘bearish’ territory over the past day, accompanied by chatter at ‘normal’ levels.&nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_09_02_062502_072406d589.png" alt="Screenshot 2026-09-02 062502.png" width="1266" height="690"><figcaption>&lt;ORCL stock retail sentiment on September 2 as of 5:45 a.m. ET | Source: Stocktwits&gt;</figcaption></figure><h2 class="st-heading-2">Cloud Growth Could Challenge The Bear Thesis</h2>The analyst said the firm likes Oracle's setup heading into its fiscal first-quarter results, despite the period being "seasonally soft." While investor sentiment around Oracle has fallen, Thill believes most of the negative expectations are already priced into the stock.&nbsp;He added that a growth inflection in Oracle’s cloud business and uptick in software-as-a-service (SaaS) “could dispel some of the bear thesis.”Jefferies trimmed price target of $320 still implies a potential upside of over 105% from Tuesday’s close.<h2 class="st-heading-2">TD Cowen Also Cuts Oracle Price Target</h2>On Tuesday, TD Cowen also&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/orcl-stock-extends-fall-overnight-after-analyst-cuts-price-target-flags-analyst-day-as-key-catalyst-retail-watches-cautiously/cZsAaBwRJub">lowered</a> its price target on Oracle to $240 from $300 while maintaining a ‘Buy’ rating. The firm flagged Oracle’s analyst day on October 28 as the next major catalyst. The event is expected to focus heavily on the company’s cloud business, with Oracle likely to issue updated fiscal 2030 targets, TD Cowen said in an investor note.Oracle closed Tuesday at roughly $141, which means TD Cowen’s $240 target implies about 70% upside.According to Koyfin data, the average 12-month price target on Oracle stands at around $242, implying a 71% upside. Out of the 44 analysts covering the stock, 36 gave Oracle a ‘Buy’ or ‘Strong Buy’ rating, with seven recommending ‘Hold’ and only one giving it a ‘Sell’ rating.<h2 class="st-heading-2">How Is Retail Feeling About ORCL Stock?</h2>One Stocktwits user described ORCL as “one of the rare names in this sector that hasn’t already run 200%+” and called it worth considering for new investors.<stembedurl>https://stocktwits.com/Eclipse01/message/663407054</stembedurl>Another investor said the stock could be a “good buying opportunity” and expected it to move higher into earnings, scheduled for September 8. Wall Street expects Oracle to report earnings per share (EPS) of $1.74 on revenue of $19.13 billion.<stembedurl>https://stocktwits.com/Risk_ON_Always/message/663405098</stembedurl>ORCL’s stock has fallen almost 30% this year and around 37% in the last 12 months. The recent pressure also comes against a difficult backdrop for technology stocks. The broader market sold off Tuesday, with the Nasdaq Composite falling about 1%.The recent pressure also comes against a difficult backdrop for technology stocks. The broader market sold off Tuesday, with the Nasdaq Composite falling about 1%, while Oracle dropped 5.23%.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/jensen-huang-says-cyberattacks-will-grow-exponentially-nvidia-crowd-strike-build-ai-superintelligence-for-cyber-defense/cZsoqYTRJMV">Jensen Huang Says Cyberattacks Will Grow ‘Exponentially’ — Nvidia, CrowdStrike Build AI ‘Superintelligence’ For Cyber Defense</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Logo of the software and hardware manufacturer Oracle at the German headquarters.

ORCL Investor Sentiment Near 'Peak-Negative' With Most Bad News Priced In, Says Jefferies

Global X Funds - Global X Artificial Intelligence & Technology ETF

Dan IVES Wedbush AI Revolution ETF

Oracle Corp.

Technology Select Sector SPDR Fund

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$38.98
Prev Close	$38.11
Open	$38.76
Dividend Yield	N/A
50-Day Moving Average	$40.02
Beta	N/A
Avg. Volume	394,366.01
PE Ratio	N/A

52-Week High	$42.75
52-Week Low	$26.92
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

IVES Fundamentals